PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsLevothyroxine
Levothyroxine
Ermeza, Euthyrox, Levo-t, Levolet, Levothyroxine, Levoxyl, Synthroid, Thyquidity, Thyro-tabs, Tirosint, Tirosint-sol, Unithroid (levothyroxine) is a small molecule pharmaceutical. Levothyroxine was first approved as Unithroid on 2000-08-21. It is used to treat autoimmune thyroiditis, goiter, myxedema, thyroid neoplasms, and thyrotoxicosis in the USA. The pharmaceutical is active against thyroid hormone receptor beta and thyroid hormone receptor alpha.
Download report
Favorite
Top Prescription Drugs
Top 200 Pharmaceuticals by Retail Sales
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
neoplasmsD009369
skin and connective tissue diseasesD017437
endocrine system diseasesD004700
immune system diseasesD007154
Trade Name
FDA
EMA
Ermeza, Euthyrox, Levo-t, Levolet, Levothyroxine, Levoxyl, Synthroid, Thyquidity, Thyro-tabs, Tirosint, Tirosint-sol, Unithroid (discontinued: Euthyrox, Levothyroxine, Levoxyl)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Levothyroxine sodium
Tradename
Company
Number
Date
Products
SYNTHROIDAbbVieN-021402 RX2002-07-24
12 products, RLD
THYRO-TABSAlvogenN-021116 RX2002-10-24
12 products, RLD
LEVO-TCediprofN-021342 RX2002-03-01
12 products
EUTHYROXEMD SeronoN-021292 RX2002-05-31
11 products
LEVOTHYROXINE SODIUMFresenius KabiN-202231 RX2011-06-24
3 products, RLD, RS
LEVOTHYROXINE SODIUMFresenius KabiN-210632 RX2019-04-11
3 products, RLD, RS
LEVOLETGenus LifesciencesN-021137 RX2003-06-06
12 products
LEVOTHYROXINE SODIUMHikma PharmaceuticalsN-214253 RX2021-05-17
1 products, RLD, RS
TIROSINTIBSA GroupN-021924 RX2006-10-13
15 products, RLD
TIROSINT-SOLIBSA GroupN-206977 RX2016-12-15
15 products, RLD, RS
Show 4 marketed
Show 2 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
adthyzaunapproved drug other2025-04-11
adthyza thyroidunapproved drug other2025-02-20
ermezaNew Drug Application2022-04-15
euthyroxNew Drug Application2024-10-24
levo-tNew Drug Application2024-07-31
levothroidNew Drug Application2012-03-02
levothyroxineNDA authorized generic2014-09-24
levothyroxine sodiumANDA2025-05-22
levoxylNew Drug Application2020-12-15
np thyroidunapproved drug other2021-05-11
Show 13 more
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Levothyroxine Sodium, Tirosint-Sol, Ibsa
112413822039-09-17U-3757, U-3758
105375382037-02-28DP
110969132037-02-28DP
Levothyroxine Sodium, Levolet, Genus Lifesciences
102319312038-03-23DP
104061082038-03-23DP
Levothyroxine Sodium, Levothyroxine Sodium, Fresenius Kabi Usa
97823762036-12-01DP
103986692036-12-01DP
111351902036-12-01DP
90062892032-10-03DP
91682382032-08-29DP
91682392032-08-29DP
Levothyroxine Sodium, Levothyroxine Sodium, Hikma
111544982036-07-20DP
Levothyroxine Sodium, Ermeza, Mylan
93457722035-02-27DP
Levothyroxine Sodium, Thyquidity, Azurity
90503072031-08-06DP
Levothyroxine Sodium, Tirosint, Ibsa
76914112024-03-14DP
77233902024-03-14DP
ATC Codes
H: Systemic hormonal preparations, excl. sex hormones and insulins
— H03: Thyroid therapy drugs
— H03A: Thyroid preparations
— H03AA: Thyroid hormones
— H03AA01: Levothyroxine sodium
— H03AA03: Combinations of levothyroxine and liothyronine
— H03AA51: Levothyroxine sodium and iodine compounds
HCPCS
No data
Clinical
Clinical Trials
264 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HypothyroidismD007037EFO_0004705E03.9516133260119
Thyroid diseasesD013959—E00-E07210483557
Thyroid neoplasmsD013964EFO_0003841—26321729
Healthy volunteers/patients———131—2116
Graves diseaseD006111EFO_0004237E05.0—13339
Congenital hypothyroidismD003409—E00.1———279
SyndromeD013577————1157
GoiterD006042EFO_0004283E04.9—1—326
RecurrenceD012008——111216
Diabetes mellitusD003920EFO_0000400E08-E1321—115
Show 47 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hashimoto diseaseD050031EFO_0003779E06.3—11—1012
PregnancyD011247EFO_0002950Z33.1——1—45
Habitual abortionD000026EFO_1000954N961—2—14
DyslipidemiasD050171————2—24
Premature birthD047928EFO_0003917O60——2—24
NeoplasmsD009369—C80—11—23
Chronic renal insufficiencyD051436—N18——1—23
Kidney diseasesD007674EFO_0003086N08——1—23
ThyrotoxicosisD013971—E05—11—13
Spontaneous abortionD000022EFO_1001255O00.11—1—13
Show 12 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ThyroiditisD013966—E06—1——1011
Autoimmune thyroiditisD013967EFO_0006812E06.3—1——89
InfertilityD007246EFO_0000545——2——35
Non-alcoholic fatty liver diseaseD065626EFO_0003095K75.8112———3
Fatty liverD005234EFO_0003934—12———3
Breast neoplasmsD001943EFO_0003869C50—1——12
Liver diseasesD008107EFO_0001421K70-K7711———2
SarcomaD012509———1———1
Alveolar soft part sarcomaD018234———1———1
Environmental biomarkersD000074062———1———1
Show 7 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HyperthyroidismD006980—E05.91———56
MelanosisD008548EFO_0003963L81.11———12
PharmacokineticsD010599——2————2
Crush injuriesD000071576—T14.81————1
Drug interactionsD004347——1————1
AnemiaD000740EFO_0004272D64.91————1
Iron-deficiency anemiaD018798—D501————1
Deficiency diseasesD003677EFO_1001067E631————1
Iron deficienciesD000090463—E61.11————1
Heart transplantationD016027EFO_0010673—1————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Pregnancy rateD018873——————44
Covid-19D000086382—U07.1————44
CarcinomaD002277—C80.0————33
HyperprolactinemiaD006966—E22.1————22
EpilepsyD004827EFO_0000474G40.9————22
Insulin resistanceD007333EFO_0002614E88.819————22
Autoimmune diseasesD001327EFO_0000540M30-M36————22
ObesityD009765EFO_0001073E66.9————22
Heart diseasesD006331EFO_0003777I51.9————22
ThyroidectomyD013965——————22
Show 68 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameLevothyroxine
INNlevothyroxine sodium
Description
L-thyroxine is the L-enantiomer of thyroxine. It has a role as a thyroid hormone, an antithyroid drug, a human metabolite and a mouse metabolite. It is a thyroxine, an iodophenol, a 2-halophenol, a L-phenylalanine derivative and a non-proteinogenic L-alpha-amino acid. It is a conjugate acid of a L-thyroxine(1-). It is an enantiomer of a D-thyroxine. It is a tautomer of a L-thyroxine zwitterion.
Classification
Small molecule
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O
Identifiers
PDB—
CAS-ID51-48-9
RxCUI—
ChEMBL IDCHEMBL1624
ChEBI ID18332
PubChem CID5819
DrugBankDB00451
UNII ID054I36CPMN (ChemIDplus, GSRS)
Target
Agency Approved
THRA
THRA
Organism
Homo sapiens
Gene name
THRA
Gene synonyms
EAR7, ERBA1, NR1A1, THRA1, THRA2
NCBI Gene ID
Protein name
thyroid hormone receptor alpha
Protein synonyms
c-erbA protooncogene, c-erbA-1, c-erbA-alpha, EAR-7, ERBA-related 7, Nuclear receptor subfamily 1 group A member 1, thyroid hormone receptor alpha 1, thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian), triiodothyronine receptor, V-erbA-related protein 7
Uniprot ID
Mouse ortholog
Thra (21833)
thyroid hormone receptor alpha (Q99146)
Alternate
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
Synthroid – AbbVie
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Levothyroxine – Amneal Pharmaceuticals
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
Levothyroxine
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 59,868 documents
View more details
Safety
Black-box Warning
Black-box warning for: Adthyza, Adthyza thyroid, Ermeza, Euthyrox, Levo-t, Levothyroxine sodium, Levoxyl, Np thyroid 60, Np thyroid 90, Sertraline hydrochloride, Synthroid, Thyquidity, Tirosint, Tirosint tirosint, Unithroid
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
67,195 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use